Year |
Citation |
Score |
2014 |
Das Gupta S, So JY, Wall B, Wahler J, Smolarek AK, Sae-Tan S, Soewono KY, Yu H, Lee MJ, Thomas PE, Yang CS, Suh N. Tocopherols inhibit oxidative and nitrosative stress in estrogen-induced early mammary hyperplasia in ACI rats. Molecular Carcinogenesis. PMID 24782330 DOI: 10.1002/Mc.22164 |
0.78 |
|
2013 |
So JY, Wahler JE, Yoon T, Smolarek AK, Lin Y, Shih WJ, Maehr H, Uskokovic M, Liby KT, Sporn MB, Suh N. Oral administration of a gemini vitamin D analog, a synthetic triterpenoid and the combination prevents mammary tumorigenesis driven by ErbB2 overexpression. Cancer Prevention Research (Philadelphia, Pa.). 6: 959-70. PMID 23856074 DOI: 10.1158/1940-6207.Capr-13-0087 |
0.809 |
|
2013 |
So JY, Smolarek AK, Salerno DM, Maehr H, Uskokovic M, Liu F, Suh N. Targeting CD44-STAT3 Signaling by Gemini Vitamin D Analog Leads to Inhibition of Invasion in Basal-Like Breast Cancer Plos One. 8. PMID 23326564 DOI: 10.1371/Journal.Pone.0054020 |
0.806 |
|
2013 |
Smolarek AK, So JY, Thomas PE, Lee HJ, Paul S, Dombrowski A, Wang CX, Saw CL, Khor TO, Kong AN, Reuhl K, Lee MJ, Yang CS, Suh N. Dietary tocopherols inhibit cell proliferation, regulate expression of ERα, PPARγ, and Nrf2, and decrease serum inflammatory markers during the development of mammary hyperplasia. Molecular Carcinogenesis. 52: 514-25. PMID 22389237 DOI: 10.1002/Mc.21886 |
0.79 |
|
2013 |
Liu F, Roy T, So JY, Smolarek A, Lu Y, Suh N. Abstract 780: Knockdown of p53 increases tumorigenicity of human breast cancer cells. Cancer Research. 73: 780-780. DOI: 10.1158/1538-7445.Am2013-780 |
0.796 |
|
2013 |
Wahler J, So JY, Smolarek A, Maehr H, Uskokovic M, Suh N. Abstract 184: A gemini vVitamin D analog, BXL0124, inhibits mammary tumorigenesis by delaying the transition of ductal carcinoma in situ to iInvasive breast carcinoma. Cancer Research. 73: 184-184. DOI: 10.1158/1538-7445.Am2013-184 |
0.808 |
|
2013 |
So JY, Smolarek AK, Maehr H, Uskokovic M, Liby K, Sporn MB, Suh N. Abstract 180: Inhibition of tumorigenesis by a novel Gemini vitamin D analog BXL0124 and a synthetic triterpenoid CDDO-Im in MMTV-HER2/neu transgenic mice. Cancer Research. 73: 180-180. DOI: 10.1158/1538-7445.Am2013-180 |
0.82 |
|
2012 |
Smolarek AK, So JY, Burgess B, Kong AN, Reuhl K, Lin Y, Shih WJ, Li G, Lee MJ, Chen YK, Yang CS, Suh N. Dietary administration of δ- and γ-tocopherol inhibits tumorigenesis in the animal model of estrogen receptor-positive, but not HER-2 breast cancer. Cancer Prevention Research (Philadelphia, Pa.). 5: 1310-20. PMID 22964476 DOI: 10.1158/1940-6207.Capr-12-0263 |
0.804 |
|
2012 |
So JY, Smolarek AK, Shah N, Maehr H, Uskokovic M, Liu F, Suh N. Abstract 929: Repression of CD44 is a key molecular action of a novel Gemini vitamin D BXL0124 to inhibit breast cancer cell invasion induced by HGF/Met signaling Cancer Research. 72: 929-929. DOI: 10.1158/1538-7445.Am2012-929 |
0.816 |
|
2011 |
Smolarek AK, Suh N. Chemopreventive activity of vitamin e in breast cancer: A focus on γ- and δ-tocopherol Nutrients. 3: 962-986. PMID 22254089 DOI: 10.3390/Nu3110962 |
0.68 |
|
2011 |
Suh N, Reddy BS, DeCastro A, Paul S, Lee HJ, Smolarek AK, So JY, Simi B, Wang CX, Janakiram NB, Steele V, Rao CV. Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats. Cancer Prevention Research (Philadelphia, Pa.). 4: 1895-902. PMID 21764859 DOI: 10.1158/1940-6207.Capr-11-0222 |
0.789 |
|
2011 |
So JY, Lee HJ, Smolarek AK, Paul S, Wang CX, Maehr H, Uskokovic M, Zheng X, Conney AH, Cai L, Liu F, Suh N. A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer. Molecular Pharmacology. 79: 360-7. PMID 21115634 DOI: 10.1124/Mol.110.068403 |
0.805 |
|
2011 |
So JY, Smolarek AK, Maehr H, Uskokovic M, Cai L, Liu F, Suh N. Abstract 839: A novel Gemini vitamin D analog represses a stem cell marker CD44 and its variant CD44v6 and inhibits CD44-Met signaling in breast cancer Cancer Research. 71: 839-839. DOI: 10.1158/1538-7445.Am2011-839 |
0.82 |
|
2011 |
Suh N, Reddy BS, Paul S, DeCastro A, Lee HJ, Smolarek AK, So JY, Simi B, Wang CX, Janakiram NB, Steele VE, Rao CV. Abstract 833: Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/beta-catenin/cyclin D1 signaling pathway in rats Cancer Research. 71: 833-833. DOI: 10.1158/1538-7445.Am2011-833 |
0.791 |
|
2011 |
Smolarek AK, So JY, Thomas PE, Lee HJ, Paul S, Dombrowski A, Wang C, Kong AT, Reuhl K, Lee M, Yang CS, Suh N. Abstract 1851: Dietary mixed tocopherols inhibit cell proliferation in mammary hyperplasia, suppress the expression of inflammatory markers, and upregulate PPARγ Cancer Research. 71: 1851-1851. DOI: 10.1158/1538-7445.Am2011-1851 |
0.77 |
|
2010 |
Lee HJ, So JY, DeCastro A, Smolarek A, Paul S, Maehr H, Uskokovic M, Suh N. Gemini vitamin D analog suppresses ErbB2-positive mammary tumor growth via inhibition of ErbB2/AKT/ERK signaling. The Journal of Steroid Biochemistry and Molecular Biology. 121: 408-12. PMID 20304052 DOI: 10.1016/J.Jsbmb.2010.03.053 |
0.789 |
|
2010 |
Paul S, DeCastro AJ, Lee HJ, Smolarek AK, So JY, Simi B, Wang CX, Zhou R, Rimando AM, Suh N. Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats. Carcinogenesis. 31: 1272-8. PMID 20061362 DOI: 10.1093/Carcin/Bgq004 |
0.791 |
|
2010 |
So JY, Lee HJ, Smolarek AK, Paul S, Maehr H, Uskokovic M, Cai L, Liu F, Suh N. Abstract 644: A novel Gemini vitamin D analogue represses the expression of a stem cell marker CD44 in breast cancer Cancer Research. 70: 644-644. DOI: 10.1158/1538-7445.Am10-644 |
0.807 |
|
2009 |
Lee HJ, Ju J, Paul S, So JY, DeCastro A, Smolarek A, Lee MJ, Yang CS, Newmark HL, Suh N. Mixed tocopherols prevent mammary tumorigenesis by inhibiting estrogen action and activating PPAR-gamma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4242-9. PMID 19509159 DOI: 10.1158/1078-0432.Ccr-08-3028 |
0.751 |
|
Show low-probability matches. |